TAC-302

· Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAC-302, covering 2025-01-20 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. [Phase 2]